To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC41925 | {Boc}-Phe-Leu-Phe-Leu-Phe |
{Boc}-Phe-Leu-Phe-Leu-Phe ({Boc}-FLFLF) is a formyl peptide receptor (FPR) family antagonist that preferentially inhibits activity triggered through the formyl peptide receptor.
More description
|
|
| DC41924 | Fetuin, Fetal Bovine Serum |
Fetuin, Fetal Bovine Serum is a liver-secreted 64 kDa plasma glycoprotein isolated from fetal bovine serum. Fetuin, Fetal Bovine Serum inhibits trypsin activity and promote cellular attachment, growth, and differentiation.
More description
|
|
| DC41920 | Angiopep-Bim BH3 hydrochloride |
Angiopep-Bim BH3 hydrochloride, a BBB penetrated peptode, could be used to investigate the permeability of CNS therapeutics.
More description
|
|
| DC41919 | Angiopep-2 hydrochloride |
Angiopep-2 hydrochloride is a brain peptide vector. The conjugation of anticancer agents with the Angiopep-2 peptide vector could increase their efficacy in the treatment of brain cancer.
More description
|
|
| DC41918 | LCKLSL hydrochloride |
LCKLSL hydrochloride is a N-terminal hexapeptide and a competitive annexin A2 (AnxA2) inhibitor. LCKLSL hydrochloride potently inhibits the binding of tissue plasminogen activator (tPA) to AnxA2. LCKLSL hydrochloride also inhibits the generation of plasmin and has anti-angiogenic roles.
More description
|
|
| DC41917 | LCKLSL |
LCKLSL is a N-terminal hexapeptide and a competitive annexin A2 (AnxA2) inhibitor. LCKLSL potently inhibits the binding of tissue plasminogen activator (tPA) to AnxA2. LCKLSL also inhibits the generation of plasmin and has anti-angiogenic roles.
More description
|
|
| DC41898 | TAT-P4-(DATC5)2 TFA |
TAT-P4-(DATC5)2 TFA is a high-affinity peptide inhibitor of the PICK1 (protein interacting with C kinase-1) PDZ domain, with a Ki of 1.7 nM. TAT-P4-(DATC5)2 TFA attenuats the reinstatement of cocaine seeking in rats.
More description
|
|
| DC41897 | TAT-P4-(DATC5)2 |
TAT-P4-(DATC5)2 is a high-affinity peptide inhibitor of the PICK1 (protein interacting with C kinase-1) PDZ domain, with a Ki of 1.7 nM. TAT-P4-(DATC5)2 attenuats the reinstatement of cocaine seeking in rats.
More description
|
|
| DC41896 | TfR-T12 TFA |
TfR-T12 TFA is a BBB-penetrated transferrin receptor (TfR) binding peptide, displaying a binding affinity in the nM range.
More description
|
|
| DC41894 | Dabcyl-KTSAVLQSGFRKME-Edans TFA |
Dabcyl-KTSAVLQSGFRKME-Edans TFA is a fluorogenic peptide. Dabcyl-KTSAVLQSGFRKME-Edans TFA is used as the substrate to measure the enzymatic activities of protease forms. Dabcyl-KTSAVLQSGFRKME-Edans TFA has the potential for study 2019-nCoV (COVID-19) infection.
More description
|
|
| DC41886 | AC 253 |
AC 253 is an Amylin (AMY3) receptor antagonist, inhibiting andrenomedulin-stimulated cAMP production. AC 253 protects against oligomeric Aβ-induced increase in intracellular Ca2+, activation of PKA, MAPK, Akt and cFOS and cell death in neuronal cell culture. AC 253 blocks electrophysiological effects of Aβ.
More description
|
|
| DC41885 | Amyloid β-Peptide (1-37) (human) |
Amyloid β-Peptide (1-37) (human) is an amyloid β-protein fragment cleaved from amyloid precursor protein (APP).
More description
|
|
| DC41879 | Histone H3 (1-34) |
Histone H3 (1-34), a peptide derived from human histone isotype 3.1, is a substrate for methyltransferase/demethylase enzymes.
More description
|
|
| DC41878 | H3K4(Me3) (1-20) |
H3K4(Me3) (1-20), a histone peptide, is a substrate for methyltransferase/demethylase enzymes.
More description
|
|
| DC41877 | H3K4(Me2) (1-20) |
H3K4(Me2) (1-20), a histone peptide, is a substrate for methyltransferase/demethylase enzymes.
More description
|
|
| DC41876 | H3K4(Me) (1-20) |
H3K4(Me) (1-20), a histone peptide, is a substrate for methyltransferase/demethylase enzymes.
More description
|
|
| DC41875 | H3K27(Me3) (15-34) |
H3K27(Me3) (15-34) is a histone peptide and a repressive mark derived from human histone isotype 3.1. H3K27(Me3) (15-34) is a substrate for methyltransferase/demethylase enzymes. The SET domain of the Polycomb Repressive Complex 2 (PRC2) component EZH2 catalyzes H3K27(Me3) tri-methylation. H3K27(Me3) can be recognized by a chromodomain protein in the canonical Polycomb Repressive Complex 1 (PRC1).
More description
|
|
| DC41874 | H3K27(Me2) (15-34) |
H3K27(Me2) (15-34) is a histone peptide and a repressive mark derived from human histone isotype 3.1. H3K27(Me2) (15-34) is a substrate for methyltransferase/demethylase enzymes. The SET domain of the Polycomb Repressive Complex 2 (PRC2) component EZH2 catalyzes H3K27(Me2) di-methylation.
More description
|
|
| DC41873 | H3K27(Me) (15-34) |
H3K27(Me) (15-34) is a histone peptide and a repressive mark derived from human histone isotype 3.1. H3K27(Me) (15-34) is a substrate for methyltransferase/demethylase enzymes. Polycomb Repressive Complex 2 (PRC2) is a multiprotein complex that catalyzes the methylation of H3K27(Me).
More description
|
|
| DC41871 | ELA-21 (human) |
ELA-21 (human) is an apelin receptor agonist with a pKi of 8.52. ELA-21 (human) completely inhibits Forskolin-induced cAMP production and stimulates β-arrestin recruitment with subnanomolar potencies. ELA-21 (human) is an agonist in G-protein-dependent and -independent pathways.
More description
|
|
| DC41870 | PAMP-12(human, porcine) TFA |
PAMP-12(human, porcine) TFA is a major component of immunoreactive (ir)-PAMP, is processed from the adrenomedullin precursor, is a potent hypotensive peptide and participates in cardiovascular control.
More description
|
|
| DC41869 | PAMP-12(human, porcine) |
PAMP-12(human, porcine) is a major component of immunoreactive (ir)-PAMP, is processed from the adrenomedullin precursor, is a potent hypotensive peptide and participates in cardiovascular control.
More description
|
|
| DC41868 | PEN(mouse) TFA |
PEN(mouse) TFA (proSAAS(221-242) TFA) is the precursor of a number of peptides that function as neuropeptides.
More description
|
|
| DC41866 | BigLEN(rat) TFA |
BigLEN(rat) TFA, one of the most abundant peptides in brain, is a potent GPR171 agonist, with an EC50 of 1.6 nM.
More description
|
|
| DC41865 | BigLEN(rat) |
BigLEN(rat), one of the most abundant peptides in brain, is a potent GPR171 agonist, with an EC50 of 1.6 nM.
More description
|
|
| DC41862 | Elabela(19-32) TFA |
Elabela(19-32) TFA is a potent apelin receptor (APJ) endogenous agonist with a Ki of 0.93 nM. Elabela(19-32) TFA activates the Gαi1 and β-arrestin-2 signaling pathways with EC50s of 8.6 nM and 166 nM. Elabela(19-32) TFA induces receptor internalization and reduces arterial pressure, exerts positive inotropic effects on the heart.
More description
|
|
| DC41857 | Amylin (IAPP), feline TFA |
Amylin (IAPP), feline TFA, a 37-amino acid polypeptide. Amylin (IAPP) is one of the major secretory products of β-cells of the pancreatic islets. Amylin (IAPP) is a regulatory peptide, which inhibits insulin and glucagon secretion.
More description
|
|
| DC41856 | AGA-(C8R) HNG17, Humanin derivative TFA |
AGA-(C8R) HNG17, Humanin derivative TFA is a potent humanin (HN) derivative. AGA-(C8R) HNG17, Humanin derivative completely suppresses neuronal cell death by Alzheimer's disease-relevant insults.
More description
|
|
| DC41854 | Gp100 (619-627) (acetate) |
Gp100 (619-627) acetate is amino acids 619 to 627 fragment of human melanoma antigen glycoprotein 100 (gp100). Gp100 has been a widely studied target for melanoma immunotherapy.
More description
|
|
| DC41850 | Peptide C105Y TFA |
Peptide C105Y TFA, a synthetic and cell-penetrating peptide based on the amino acid sequence corresponding to residues 359-374 of α1-antitrypsin, enhances gene expression from DNA nanoparticles.
More description
|
|